Biyun Tian
Biyun Tian was founded in 2001 by international students working and studying at Harvard University. For over 20 years, we have been dedicated to independent research and development as well as production. Established in 2007, Shanghai Biyuntian Biotechnology Co., Ltd. is a national level specialized, refined, unique, and new "Little Giant" enterprise. It was further selected as one of the second batch of national level specialized, refined, unique, and new "Little Giant" enterprises recommended for support in the first year. It is also a Shanghai Science and Technology Little Giant Enterprise, a leading enterprise in the G60 Science and Technology Innovation Corridor, one of the top 100 private enterprises driving science and technology innovation in the Yangtze River Delta G60 Science and Technology Innovation Corridor, a "TOP100" brand value list for Shanghai specialized, refined, unique, and new "Little Giant" enterprises, a Shanghai specialized, refined, unique, and new small and medium-sized enterprise, and a Shanghai high-tech enterprise. It is also an executive director unit of the China Inspection and Testing Society and a director unit of the Scientific Research Reagent Branch of the. The company mainly develops and produces reagents, test kits, consumables, and equipment for biological and medical research, while providing technical services for life science research and a one-stop platform for purchasing experimental instruments and equipment
Recommended Posts
-
Researchers have found that their appendix tissue has protein clusters similar to those observed in the brains of Parkinson's disease patients. This discovery suggests that the appendix plays a role in the early stages of this disease by aggregating these same proteins. These proteins contribute to Parkinson's disease in some way, so appendectomy may prevent their harmful activity. Researchers have found that their appendix tissue has protein clusters similar to those observed in the brains of Parkinson's disease patients. This discovery suggests that the appendix plays a role in the early stages of this disease by aggregating these same proteins. These proteins contribute to Parkinson's disease in some way, so appendectomy may prevent their harmful activity. -
Recently, a landmark study on neural cells was published, in which researchers claimed to have discovered that brain neurons can modify their own DNA on their own. For a long time, the biomedical community has believed that human somatic DNA is fixed. According to Science, the discovery that "brain cells can modify their own DNA" has been evaluated as "possibly one of the major discoveries in the field of molecular biology in recent years". Researchers analyzed the donated brains of 6 healthy elderly individuals and 7 non secondary Alzheimer's disease patients and found that patients with Alzheimer's disease carry six times more APP variant gene varieties in their neuronal cells than the general population. Therefore, researchers speculate that the ability of brain cells to modify DNA on their own may contribute to the development of Alzheimer's disease.
-
Under the trend of domestic substitution in the medical device industry, the drive to explore overseas markets is also increasing. Going global is the key for the medical device industry to seek new growth curves and enhance international competitiveness.Moreover, China is implementing a more proactive opening-up strategy. Jointly building the "the Belt and Road" has become a popular international public product and international cooperation platform to achieve higher quality and deeper mutual benefit and win-win results with countries along the line.
